Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups
Rebecca S Campbell,1 Paresh Chaudhari,2 Harlen D Hays,1 Robert J Taylor,1 Brian H Nathanson,3 Samuel A Bozzette,1 David Horn4 1Cerner Research, Culver City, CA, USA; 2Astellas Scientific and Medical Affairs, Inc., Northbrook, IL, USA; 3OptiStatim, LLC, Longmeadow, MA, USA; 4David Horn LLC, Doylestow...
Main Authors: | Campbell RS, Chaudhari P, Hays HD, Taylor RJ, Nathanson BH, Bozzette SA, Horn DL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-10-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/outcomes-associated-with-conventional-versus-lipid-based-formulations--a14779 |
Similar Items
-
Design of amphotericin B oral formulation for antifungal therapy
by: Min Liu, et al.
Published: (2017-01-01) -
Different liposomal amphotericin B formulations for visceral leishmaniasis
by: Thomas P C Dorlo, et al.
Published: (2014-08-01) -
Comparison of extracorporeal and conventional cardiopulmonary resuscitation: a retrospective propensity score matched study
by: Daniel Patricio, et al.
Published: (2019-01-01) -
Comparison of Sutureless and Conventional Laparoscopic Partial Nephrectomy: A Propensity Score-Matching Analysis
by: Feng Zhang, et al.
Published: (2021-03-01) -
Pharmaceutical studies of Amphotericin-B : oral formulation using nanotechnology
by: Al Quadeib, Bushra
Published: (2016)